News tagged with hiv infection
San Francisco startup makes data science a sport
(AP) -- Strange secrets hide in numbers. For instance, an orange used car is least likely to be a lemon. This particular unexpected finding came to light courtesy of a data jockey who goes by the Internet ...
Technology / Computer Sciences
Apr 15, 2012 |
4 / 5 (1) |
0
More and more children have no parents and grandparents
(PhysOrg.com) -- While the number of cases of HIV infection in Zimbabwe has been decreasing for some time, the circumstances of children who have lost both parents to the AIDS epidemic could worsen in the ...
Other Sciences / Social Sciences
Mar 28, 2012 |
not rated yet |
3
Study provides new insights into an ancient mechanism of mammalian evolution
A team of geneticists and computational biologists in the UK today reveal how an ancient mechanism is involved in gene control and continues to drive genome evolution. The new study is published in the journal ...
Jan 12, 2012 |
4.6 / 5 (5) |
0
|
UN investigator says medical waste risks ignored
(AP) -- A human rights investigator for the United Nations says up to a quarter of the world's trash from hospitals, clinics, labs, blood banks and mortuaries is hazardous and much more needs to be done to ...
Sep 14, 2011 |
not rated yet |
0
Scientists uncover new factor in HIV infection
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cellsa process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes ...
Aug 24, 2011 |
5 / 5 (2) |
0
|
Entry prohibited for AIDS viruses: Peptide triazole inhibitors disrupt cell-free HIV-1
(PhysOrg.com) -- The initial entry of HIV-1 into host cells remains a compelling yet elusive target for the development of agents to prevent infection, a critical need in the fight against the global AIDS ...
Jul 08, 2011 |
not rated yet |
1
AIDS drug supplies dwindling in Swaziland
(AP) -- Cash-strapped Swaziland's state hospitals have only two months' supplies of AIDS drugs, the country's health minister has told parliament in an assessment that AIDS patients and activists took as a death sentence.
Medicine & Health / HIV & AIDS
Jun 28, 2011 |
not rated yet |
0
Premature aging seen as issue for AIDS survivors
(AP) -- Having survived the first and worst years of the AIDS epidemic, when he was losing three friends to the disease in a day and undergoing every primitive, toxic treatment that then existed, Peter Greene ...
Medicine & Health / HIV & AIDS
Jun 11, 2011 |
not rated yet |
1
UN summit adopts AIDS targets amid condom storm
A UN summit on Friday ordered a huge expansion in AIDS treatment, but sparked protests by the Vatican and some Muslim nations over its endorsement of condoms and calls to help prostitutes, gays and drug users.
Medicine & Health / HIV & AIDS
Jun 11, 2011 |
5 / 5 (1) |
1
UN-led alliance focuses on young people and AIDS
(AP) -- When AIDS counselor Patience Ncusani urges teens in her Soweto neighborhood to wait to have sex, or cautions young women that an older boyfriend can be deadly, she has special rapport.
Medicine & Health / HIV & AIDS
Jun 01, 2011 |
not rated yet |
0
A sweet defense against lethal bacteria
(PhysOrg.com) -- There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max ...
May 31, 2011 |
3.8 / 5 (4) |
0
|
How TRIM5 fights HIV
Thanks to a certain protein, rhesus monkeys are resistant to HIV. Known as TRIM5, the protein prevents the HI virus from multiplying once it has entered the cell. Researchers from the universities of Geneva and Zurich have ...
Medicine & Health / HIV & AIDS
Apr 20, 2011 |
not rated yet |
0
|
Oral pill trial to halt HIV in women is stopped
A trial of an oral pill aimed at preventing HIV infection in African women has been halted due to poor results, the trial operator Family Health International announced this week.
Medicine & Health / HIV & AIDS
Apr 19, 2011 |
not rated yet |
0
HIV protein unveils vaccine target
(PhysOrg.com) -- An international study headed by a UC Davis scientist describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet ...
Medicine & Health / HIV & AIDS
Mar 31, 2011 |
5 / 5 (4) |
0
|
Transmissible treatment proposed for HIV could target superspreaders to curb epidemic
Biochemist Leor Weinberger and colleagues at the University of California, San Diego and UCLA have proposed a fundamentally new intervention for the HIV/AIDS epidemic based on engineered, virus-like particles that could subdue ...
Medicine & Health / HIV & AIDS
Mar 17, 2011 |
5 / 5 (1) |
2
|
HIV
Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. The four major routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (Vertical transmission). Screening of blood products for HIV has largely eliminated transmission through blood transfusions or infected blood products in the developed world.
HIV infection in humans is now pandemic. From 1981 to 2006, AIDS killed more than 25 million people. HIV infects about 0.6 percent of the world's population. In 2005 alone, AIDS claimed an estimated 2.4–3.3 million lives, of which more than 570,000 were children. A third of these deaths are occurring in sub-Saharan Africa, retarding economic growth and increasing poverty. According to current estimates, HIV is set to infect 90 million people in Africa, resulting in a minimum estimate of 18 million orphans. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but routine access to antiretroviral medication is not available in all countries.
HIV primarily infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through three main mechanisms: firstly, direct viral killing of infected cells; secondly, increased rates of apoptosis in infected cells; and thirdly, killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.
Eventually most HIV-infected individuals develop AIDS. These individuals mostly die from opportunistic infections or malignancies associated with the progressive failure of the immune system. Without treatment, about 9 out of every 10 persons with HIV will progress to AIDS after 10–15 years. Many progress much sooner. Treatment with anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy (as of 2005) is estimated to be more than 5 years. Without antiretroviral therapy, death normally occurs within a year.
For more information about HIV, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.